Publications

2023

Ruan J, Moskowitz A, Mehta-Shah N, Sokol L, Chen Z, Kotlov N, et al. Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL. Blood. 2023;141(18):2194-2205.
Sun J, Hu L, Bok S, Yallowitz AR, Cung M, McCormick J, et al. Discovery of a Vertebral Skeletal Stem Cell Driving Spinal Metastases. Res Sq. 2023.
Girardi NI, Cushing MM. Pick Your Poison: Anemia or Transfusion. Ann Thorac Surg. 2023;116(5):1119.
Mlynarczyk C, Teater M, Pae J, Chin CR, Wang L, Arulraj T, et al. BTG1 mutation yields supercompetitive B cells primed for malignant transformation. Science. 2023;379(6629):eabj7412.
Sasset L, Chowdhury KH, Manzo OL, Rubinelli L, Konrad C, J Maschek A, et al. Sphingosine-1-phosphate controls endothelial sphingolipid homeostasis via ORMDL. EMBO Rep. 2023;24(1):e54689.
Liu W, Newhall KP, Khani F, Barlow LM, Nguyen D, Gu L, et al. The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer. Cancer Res. 2023;83(4):506-520.
Boyraz B, Gogakos T, Raskin KA, Nielsen GP. Metastatic Uterine Leiomyosarcoma With Rhabdomyosarcomatous Heterologous Differentiation. Int J Gynecol Pathol. 2023;42(2):151-154.
Stein BD, Ferrarone JR, Gardner EE, Chang JW, Wu D, Hollstein PE, et al. LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma. Cancer Discov. 2023;13(4):1002-1025.
Beg S, Zanettini C, Queiroz L, Marchionni L, Alperstein SA, Siddiqui MT. Optimal fluid volume for detecting malignancy in serous effusions: a single institution experience. J Am Soc Cytopathol. 2023;12(6):415-422.
Adegbite BO, Abramson MH, Gutgarts V, Musteata FM, Chauhan K, Muwonge AN, et al. Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity. Clin J Am Soc Nephrol. 2023;18(9):1175-1185.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700